MedPath

Argon Plasma Coagulation and Clip for the Prophylaxis of Post-polypectomy Bleeding After Hot Snare Polypectomy

Not Applicable
Conditions
Post-polypectomy Bleeding
Colorectal Polyp
Interventions
Procedure: argon plasma coagulation
Procedure: clip closure
Registration Number
NCT05250518
Lead Sponsor
Renmin Hospital of Wuhan University
Brief Summary

Discuss the efficacy and safety of argon plasma coagulation (APC)in comparison with clip closure for preventing colorectal post-procedure bleeding(PPB) after hot snare polypectomy(HSP); analyze the risk factors and the cost-effectiveness of bleeding prophylaxis strategies with Decision Tree Analytical Method.

Detailed Description

This is a multicenter, randomized and controlled study. It aims to discuss the efficacy and safety of argon plasma coagulation(APC)in comparison with clip closure for preventing colorectal post-procedure bleeding(PPB) after hot snare polypectomy(HSP), and analyze the risk factors and the cost-effectiveness of bleeding prophylaxis strategies with Decision Tree Analytical Method.

According to the prophylaxis measures, patients enrolled in this study will be randomized into the control group, APC group and Clip group. It will collect participants' data of baseline character, postoperative and follow-up. All statistical analyses will be performed by SPSS 26.0 and Tree Age Pro 2011.

Based on the previous studies, it is presumed that the rate of PPB for the control group, Clip group and APC group is 8%, 2% and 2%. Given two-side testing, an alpha of 0.05 and a power of 90%, allowing for a 5% dropout rate, the smallest sample size is 1287.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1017
Inclusion Criteria
  1. age>18 years
  2. the diagnosis of colorectal polyps is clear(Paris Ip or Ⅰsp)
  3. head diameter≥ 10 mm
  4. HSP indications were met and no contraindications were found
  5. patients (or the legal representative/guardian) with informed consent
Read More
Exclusion Criteria
  1. ASA Grade Ⅲ or above, or end-stage disease of major organs (such as malignancy, heart failure, chronic obstructive pulmonary disease, end-stage renal disease and so on)
  2. coagulation dysfunction (INR ≥ 1.5, PLT < 50×10 ^9 / L)
  3. use antiplatelet drugs within 7 days before the operation, anticoagulant drugs within 5 days, and/or blood products within 30 days after the operation
  4. there were other lesions in the resection site of the included polyps affecting this study, or the intestinal preparation was insufficient
  5. incomplete closure of clips (complete closure: spacing between adjacent clips < 1cm)
  6. APC is used for polypectomy or intraoperative hemostasis, rather than preventing PPB
  7. surgical treatment, vascular intervention, or blood products were used during the operation
  8. use other methods to prevent PPB
  9. the bleeding site was not confirmed by endoscopy
  10. history of intestinal surgery
  11. menstruation or pregnancy
  12. not following medical advice
  13. participated in other clinical trials and signed its informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
APC groupargon plasma coagulationThe APC group will receive prophylaxis of post-procedure bleeding with argon plasma coagulation.
Clip groupclip closureThe Clip group will receive prophylaxis of post-procedure bleeding with clip closure.
Primary Outcome Measures
NameTimeMethod
The rate of re-bleeding30 days after HSP

the rate of re-bleeding within 30 days after operation

Secondary Outcome Measures
NameTimeMethod
Location of re-bleeding sites30 days after HSP

the original polyps' location of re-bleeding sites: cecum, ascending colon, colonic hepatic flexure, transverse colon, colonic splenic flexure , descending colon, sigmoid colon, rectum

Other postoperative complications30 days after HSP

Other postoperative complications (perforation, electrocoagulation syndrome after polypectomy, stenosis, etc.)

Expenses of preventionthe 1 day of discharge from medical centers

Expenses of argon plasma coagulation and clips

Trial Locations

Locations (1)

Renmin Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath